SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 153 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,657,020 | +913.4% | 114,923 | +1049.2% | 0.00% | – |
| Q2 2023 | $262,200 | +6706.9% | 10,000 | -93.3% | 0.00% | -100.0% |
| Q1 2023 | $3,852 | +8.7% | 149,655 | +9.8% | 0.00% | 0.0% |
| Q4 2022 | $3,544 | -99.9% | 136,246 | -20.1% | 0.00% | -33.3% |
| Q3 2022 | $4,867,000 | +210.4% | 170,597 | +167.9% | 0.00% | +200.0% |
| Q2 2022 | $1,568,000 | +68.8% | 63,672 | +324.8% | 0.00% | – |
| Q4 2021 | $929,000 | -68.0% | 14,990 | -67.2% | 0.00% | -100.0% |
| Q3 2021 | $2,903,000 | -49.4% | 45,757 | -41.3% | 0.00% | -50.0% |
| Q1 2021 | $5,738,000 | -34.3% | 77,990 | -35.2% | 0.00% | -33.3% |
| Q4 2020 | $8,731,000 | +15.0% | 120,393 | -24.4% | 0.01% | -33.3% |
| Q3 2020 | $7,589,000 | -38.1% | 159,205 | -45.5% | 0.01% | -47.1% |
| Q2 2020 | $12,264,000 | +647.3% | 292,008 | +380.6% | 0.02% | +325.0% |
| Q1 2020 | $1,641,000 | +645.9% | 60,760 | +961.7% | 0.00% | – |
| Q4 2019 | $220,000 | -97.5% | 5,723 | -98.6% | 0.00% | -100.0% |
| Q3 2019 | $8,750,000 | – | 403,613 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,081,307 | $79,313 | 9.91% |
| Finepoint Capital LP | 614,231 | $15,810,306 | 6.04% |
| M28 Capital Management LP | 197,700 | $5,088,798 | 5.75% |
| Boxer Capital, LLC | 3,421,541 | $88,070 | 4.33% |
| Deep Track Capital, LP | 3,100,000 | $79,794,000 | 3.28% |
| EcoR1 Capital, LLC | 3,460,208 | $89,065,754 | 2.87% |
| Artal Group S.A. | 1,817,349 | $46,779 | 2.78% |
| Orbimed Advisors | 4,498,900 | $115,801,686 | 2.27% |
| Perceptive Advisors | 2,079,352 | $53,522,520 | 1.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 317,625 | $8,175,668 | 1.37% |